Solasta Ventures
Home Approach Portfolio
News Team Hatchery Contact
HomeApproachPortfolio
Solasta Ventures
NewsTeamHatcheryContact
HotSpot Therapeutics Completes $65 Million Series B Financing to Advance Pipeline of Novel Allosteric Medicines
Nia JulianMay 21, 2020
Facebook0 Twitter Pinterest0 0 Likes
Previous

Kymera, raising $173M+, becomes the 48th biotech IPO of the year as 2020 surpasses 2019

Nia JulianAugust 21, 2020
Next

Atea Pharmaceuticals Announces IND Clearance of AT-527 for COVID-19 and $215 Million Financing

Nia JulianMay 20, 2020

© 2020 Solasta Ventures. All Rights Reserved.